Types of laxatives

Laxatives are medicines that relieve constipation (difficulty with bowel movements). They are a popular type of over-the-counter remedy. They can also be prescribed for conditions that could get wor...

The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...

Perrigo net sales increase 18% to $920M in third quarter 2013

Perrigo Company today announced results for its third quarter ended March 30, 2013.Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered...

Cadence and Perrigo settle patent dispute

Cadence Pharmaceuticals Inc. said Wednesday that it settled a patent dispute with Perrigo Co. on its only marketed drug, the fever and pain treatment Ofirmev.Under the settlement Perrigo Co. can star...

Perrigo launches generic version of heartburn drug

Generic drugmaker Perrigo Co. said Friday it received U.S. approval to market a generic version of Novartis' over-the-counter heart burn medication Prevacid.Perrigo said in a statement it has already...

Analyst upgrades Perrigo on Sergeant's acquisition

An analyst boosted Perrigo's rating and price target on Friday after the company said it is buying animal healthcare company Sergeant's Pet Care Products Inc. for $285 million.Late Thursday, Perrigo...

Perrigo Company übertrifft Gewinnerwartungen

Allegan (BoerseGo.de) - Der US-Pharmakonzern Perrigo Company mit Sitz in Allegan (Bundesstaat Michigan) hat im zweiten Quartal des Geschäftsjahres 2012/13 einen Umsatz von 883 Millionen US-Dollar e.....

Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%

ALLEGAN, Mich., Aug. 9, 2012 /- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug app...

Perrigo Company Announces Quarterly Dividend

ALLEGAN, Mich., May 2, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on June 18, 2...

AAPS PharmSciTech: Development and Clinical Evaluation of Clotrimazole–β-Cyclodextrin Eyedrops for the Treatment of Fungal Keratitis

Type: Original PaperFungal keratitis is a serious corneal disease that may result in loss of vision. There are limited treatment options available in Iraqi eye hospitals which might be the main reason...

Distribution and persistence of topical clotrimazole after sinus infusion in normal canine cadavers.

Objectives: To determine the in vitro persistence of clotrimazole 1% cream in the canine frontal sinus and to evaluate the distribution of clotrimazole solution over the sino-nasal mucosa using a prev...

Effect of clotrimazole on cytosolic Ca(2+) rise and viability in HA59T human hepatoma cells.

Abstract Clotrimazole is an antimycotic imidazole derivative that interferes with cellular Ca(2+) homeostasis. This study examined the effect of clotrimazole on cytosolic Ca(2+) concentrations ([Ca(2+...

Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.

Tumor cells are characterized by their high rate of glycolysis and clotrimazole has been shown to disrupt the glycolysis pathway thereby arresting the cells in the G1 cell cycle phase. Herein, we pres...

In vitro synergistic activity of diketopiperazines alone and in combination with amphotericin B or clotrimazole against Candida albicans.

The synergistic anticandidal activity of three diketopiperazines [cyclo-(L-Pro-L-Leu) (1), cyclo-(D-Pro-L-Leu) (2), and cyclo-(D-Pro-L-Tyr) (3)] purified from a Bacillus sp. N strain associated with e...

Effect of in vivo chronic exposure to clotrimazole on zebrafish testis function.

Clotrimazole is an azole fungicide used as a human pharmaceutical that is known to inhibit cytochrome P450 (CYP) enzymatic activities, including several steroidogenic CYP. In a previous report, we sho...